Search News

Latest News

Premium

What analysts are saying about Playa Hotels (NASDAQ: PLYA) post Q1 announcement
Here’s why Wells Fargo believes Ventas Inc. (NYSE: VTR) is a ‘Buy’

Premium

Analysts revise ratings on Fabrinet (NYSE: FN) post Q3 announcement

Premium

Brokers retain “Buy” rating on Disc Medicine (NASDAQ: IRON) despite Q1 loss

Disclaimer

Kalkine Equities LLC., having Delaware File Number 4697384 is authorised to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions.

The link to our Terms & Conditions and Privacy Policy of our services have been provided for your reference.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms and Conditions